Follow
Tom Eirik Mollnes
Tom Eirik Mollnes
UiO, NLSH
Verified email at medisin.uio.no
Title
Cited by
Cited by
Year
Complement and coagulation: strangers or partners in crime?
MM Markiewski, B Nilsson, KN Ekdahl, TE Mollnes, JD Lambris
Trends in immunology 28 (4), 184-192, 2007
7102007
Essential role of the C5a receptor in E coli–induced oxidative burst and phagocytosis revealed by a novel lepirudin-based human whole blood model of inflammation
TE Mollnes, OL Brekke, M Fung, H Fure, D Christiansen, G Bergseth, ...
Blood, The Journal of the American Society of Hematology 100 (5), 1869-1877, 2002
5652002
The role of complement in biomaterial-induced inflammation
B Nilsson, KN Ekdahl, TE Mollnes, JD Lambris
Molecular immunology 44 (1-3), 82-94, 2007
5282007
Quantification of the terminal complement complex in human plasma by an enzyme‐linked immunosorbent assay based on monoclonal antibodies against a neoantigen of the complex
TE Mollnes, T Lea, SS Frøland, M Harboe
Scandinavian journal of immunology 22 (2), 197-202, 1985
3851985
The quantitative role of alternative pathway amplification in classical pathway induced terminal complement activation
M Harboe, G Ulvund, L Vien, M Fung, TE Mollnes
Clinical & Experimental Immunology 138 (3), 439-446, 2004
3842004
The alternative complement pathway revisited
M Harboe, TE Mollnes
Journal of cellular and molecular medicine 12 (4), 1074-1084, 2008
3752008
Innate immune responses to danger signals in systemic inflammatory response syndrome and sepsis
A Castellheim, OL Brekke, T Espevik, M Harboe, TE Mollnes
Scandinavian journal of immunology 69 (6), 479-491, 2009
3442009
Functional analysis of the classical, alternative, and MBL pathways of the complement system: standardization and validation of a simple ELISA
MA Seelen, A Roos, J Wieslander, TE Mollnes, AG Sjöholm, R Wurzner, ...
Journal of immunological methods 296 (1-2), 187-198, 2005
3442005
Systemic complement activation is associated with respiratory failure in COVID-19 hospitalized patients
JC Holter, SE Pischke, E de Boer, A Lind, S Jenum, AR Holten, K Tonby, ...
Proceedings of the National Academy of Sciences 117 (40), 25018-25025, 2020
3222020
Reduced complement activation with heparin-coated oxygenator and tubings in coronary bypass operations
V Videm, JL Svennevig, E Fosse, G Semb, TE Mollnes, H Nielsen
The Journal of thoracic and cardiovascular surgery 103 (4), 806-813, 1992
2981992
Cholesterol crystals induce complement-dependent inflammasome activation and cytokine release
EO Samstad, N Niyonzima, S Nymo, MH Aune, L Ryan, SS Bakke, ...
The Journal of Immunology 192 (6), 2837-2845, 2014
2722014
Complement activation and endotoxin levels in systemic meningococcal disease
P Brandtzaeg, TE Mollnes, P Kierulf
Journal of Infectious Diseases 160 (1), 58-65, 1989
2541989
Systemic inflammatory markers in COPD: results from the Bergen COPD Cohort Study
TML Eagan, T Ueland, PD Wagner, JA Hardie, TE Mollnes, JK Damås, ...
European Respiratory Journal 35 (3), 540-548, 2010
2512010
Exercise reduces plasma levels of the chemokines MCP-1 and IL-8 in subjects with the metabolic syndrome
M Trøseid, KT Lappegård, T Claudi, JK Damås, L Mørkrid, R Brendberg, ...
European heart journal 25 (4), 349-355, 2004
2452004
Hereditary porcine membranoproliferative glomerulonephritis type II is caused by factor H deficiency.
K Høgåsen, JH Jansen, TE Mollnes, J Hovdenes, M Harboe
The Journal of clinical investigation 95 (3), 1054-1061, 1995
2451995
The Rab11a GTPase controls Toll-like receptor 4-induced activation of interferon regulatory factor-3 on phagosomes
H Husebye, MH Aune, J Stenvik, E Samstad, F Skjeldal, Ø Halaas, ...
Immunity 33 (4), 583-596, 2010
2352010
Complement in inflammatory tissue damage and disease
TE Mollnes, WC Song, JD Lambris
Trends in immunology 23 (2), 61-64, 2002
2242002
Monoclonal antibodies recognizing a neoantigen of poly (C9) detect the human terminal complement complex in tissue and plasma
TE Mollnes, T Lea, M Harboe, J Tschopp
Scandinavian journal of immunology 22 (2), 183-195, 1985
2181985
An international serum standard for application in assays to detect human complement activation products
G Bergseth, JK Ludviksen, M Kirschfink, PC Giclas, B Nilsson, TE Mollnes
Molecular immunology 56 (3), 232-239, 2013
2092013
C-reactive protein, infarct size, microvascular obstruction, and left-ventricular remodelling following acute myocardial infarction
S Ørn, C Manhenke, T Ueland, JK Damås, TE Mollnes, T Edvardsen, ...
European heart journal 30 (10), 1180-1186, 2009
2042009
The system can't perform the operation now. Try again later.
Articles 1–20